JF
ALPN

Jump Financial’s Alpine Immune Sciences Inc ALPN Stock Holding History

Jump Financial’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-55,720
Closed -$1.06M – 2410
2023
Q4 		$1.06M Buy
+55,720
New +$774K 0.03% 692
2022
Q4 		– Sell
-10,013
Closed -$72K – 2117
2022
Q3 		$72K Buy
+10,013
New +$82.5K ﹤0.01% 1476
2022
Q1 		– Sell
-12,600
Closed -$175K – 2003
2021
Q4 		$175K Buy
+12,600
New +$156K 0.01% 1142

Other funds holding ALPN

DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Jump Financial's ALPN Position: Q1 2024 in Review

Jump Financial sold out of Alpine Immune Sciences Inc (ALPN) in Q1 2024, closing a stake of 55,720 shares — an estimated $1.06M sold.

Jump Financial first reported a position in ALPN in Q4 2021 and held it in 3 quarters. The position peaked at $1.06M in Q4 2023. 180 funds tracked by Wall St. Rank hold ALPN as of Q1 2024.

  • Jump Financial reported no remaining Alpine Immune Sciences Inc position as of Q1 2024 after selling out during the quarter.
  • Jump Financial sold 55,720 Alpine Immune Sciences Inc shares in Q1 2024, an estimated $1.06M.
  • Jump Financial first reported a position in Alpine Immune Sciences Inc in Q4 2021 and held it in 3 quarters.
  • Jump Financial's Alpine Immune Sciences Inc position peaked at $1.06M in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q1 2024.

Based on Jump Financial's 13F filing for Q1 2024, filed 13 May 2024.